Refresh

KDL Biotech Ltd. - Research Center

532291 KOPDRUGS Group (Z) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 14 Mar ' 13 Sep ' 12 Mar ' 12 Sep ' 11

Sales

- 9.12 11.42 13.19 13.56

Operating profit

-0.61 -0.99 -1.81 -0.99 -0.85

Interest

2.45 3.45 3.41 3.42 3.33

Gross profit

-2.98 -4.25 -5.06 -4.11 -4.01

EPS (Rs)

-2.68 -3.20 -3.55 -3.45 -3.73
Half yearly  results in details
Sep ' 14 Mar ' 13 Sep ' 12 Mar ' 12 Sep ' 11

Other income

0.07 0.20 0.16 0.30 0.16

Stock adjustment

- -0.38 - - -

Raw material

- 0.34 0.60 0.04 0.25

Power and fuel

- - - - -

Employee expenses

0.18 3.90 5.03 4.95 4.85

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

0.43 6.26 7.60 9.19 9.31

Provisions made

- - - - -

Depreciation

3.46 3.44 3.46 4.21 4.95

Taxation

- - - - -

Net profit / loss

-6.44 -7.68 -8.52 -8.28 -8.96

Extra ordinary item

- - - - -

Prior year adjustments

- - - 0.03 -

Equity capital

24.04 24.04 24.04 24.04 24.04

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

74.85 74.85 74.85 74.85 74.85

Agg.of non promotoholding (%)

31.14 31.14 31.14 31.14 31.14

OPM (%)

- -10.89 -15.89 -7.51 -6.26

GPM (%)

- -45.56 -43.73 -30.46 -29.23

NPM (%)

- -82.45 -73.63 -61.39 -65.28
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com